- Home
- BLFS vs BTZ Comparison
BLFS vs BTZ Comparison
Compare BLFS & BTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BLFS | BTZ |
|---|---|---|
| Founded | 1987 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 998.6M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | BLFS | BTZ |
|---|---|---|
| Price | $20.63 | $10.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $32.00 | N/A |
| AVG Volume (30 Days) | ★ 436.8K | 264.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.40% |
| EPS Growth | ★ 77.27 | N/A |
| EPS | N/A | ★ 1.41 |
| Revenue | ★ $96,214,000.00 | N/A |
| Revenue This Year | $19.20 | N/A |
| Revenue Next Year | $18.07 | N/A |
| P/E Ratio | ★ N/A | $7.45 |
| Revenue Growth | ★ 16.97 | N/A |
| 52 Week Low | $19.15 | $9.54 |
| 52 Week High | $29.57 | $11.18 |
Technical Indicators
Market Signals| Indicator | BLFS | BTZ |
|---|---|---|
| Relative Strength Index (RSI) | 37.91 | 31.39 |
| Support Level | $20.54 | $10.38 |
| Resistance Level | $23.00 | $10.84 |
| Average True Range (ATR) | 1.03 | 0.07 |
| MACD | -0.12 | -0.02 |
| Stochastic Oscillator | 18.94 | 15.15 |
Price Performance
Historical ComparisonAbout BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
About BTZ BlackRock Credit Allocation Income Trust
Blackrock Credit Allocation Income Trust is a diversified, closed-end Trust engaged in providing investment advisory and risk management solutions. Its investment objective is to seek current income, current gains, and capital appreciation. The company invests under normal market conditions, at least 80% of its assets in credit-related securities, including, but not limited to, investment-grade corporate bonds, high-yields, bank loans, preferred securities or convertible bonds, or derivatives with economic characteristics similar to these credit-related securities.